NDA Analytics

NDA Analytics was rebranded as part of the Envigo group in Sept 2015. The group is a cGMP contract testing laboratory, providing analytical services in support of product development and manufacture to biologics and pharmaceutical companies worldwide. NDA Analytics has extensive expertise in NCE's, recombinant protein, monoclonal antibody, vaccine, enzyme replacement therapies and nucleic acid products, with more than 20 years experience in providing methods development & validation, stability testing and lot release. Our staff include leading industry experts, senior scientists and a team of highly skilled technicians. Add first rate laboratories equipped with latest technologies and we can offer you a world class solution. This mix of experience and expertise has helped to successfully guide numerous biologic products through development and on to the market. These include recombinant proteins, monoclonal antibodies, peptides, enzyme replacement therapies, vaccines, DNA vaccines, gene therapies and oligonucleotides.